Active rheumatoid arthritis (RA) may be associated with 'anaemia of chronic disorders'. This anaemia is characterised by hypoferraemia, a decreased total iron binding capacity, a reduced transferrin saturation, a decreased amount of bone marrow sideroblasts, and normal or increased iron stores in the mononuclear phagocytes of the reticuloendothelial system of the bone marrow. ' The degree of anaemia corresponds with the RA activity.2 This anaemia may respond to anti-inflammatory and disease modifying therapy. In many cases iron deficiency coexists with anaemia of chronic disorders. This may result in diagnostic difficulties.3 In these cases iron treatment may raise the haemoglobin concentration only so far as iron deficiency contributes to its deficit. In that situation anaemia of chronic disorders alone can be held responsible for the remaining part of the anaemia.
In subjects without inflammation an iron absorption test may be useful to of radioiron has only been studied in small heterogeneous groups of patients with RA.7 In these studies a diminished absorption of iron was reported.
In the present study we investigated the absorption of iron in groups of women with and without RA and with normal and depleted reticuloendothelial iron stores. The method used distinguishes between two steps of iron absorption: 'mucosal uptake' (the amount of iron taken up by the mucosal cells from the lumen of the gut) and 'mucosal transfer' (the fraction of iron taken up by the mucosal cells, which is transported to the blood). 
Results
Figs la, b, and c show the remarkable differences in iron absorption found between control subjects and patients with active rheumatoid arthritis. Iron retention ( Fig. la) had decreased in patients with active RA, both with and without stainable iron in the bone marrow reticuloendothelial cells, compared with normal and iron deficient control subjects respectively (p<0.01). In iron deficient patients with RA retention of iron was higher than in those with normal iron stores (p<002). Nine of 17 iron deficient patients with RA had iron retention values below the range of subjects with uncomplicated iron deficiency. Analysis of the two steps in iron absorption showed that mucosal uptake of iron in patients with RA with normal bone marrow iron stores did not differ significantly from the uptake in controls (p>010) (Fig. lb) . Mucosal uptake was much lower in iron deficient RA patients than in subjects with uncomplicated iron deficiency (p<001).
Mucosal transfer of iron (Fig. lc) appeared to be lower in patients with RA with normal bone marrow iron stores than in normal controls (p<0-01). In patients with RA with depleted bone marrow iron stores mucosal transfer of iron had increased considerably compared with those with normal iron stores (p<0-01) to a concentration not significantly different from that in iron deficient control subjects (p>O. 10).
We tried to relate the iron absorption values in the patients with active RA to the degree of disease activity and to parameters that may be involved in the regulation of iron absorption ( tThe correlation coefficients for n-2 and their significance are indicated. tBM=bone marrow; for other abbreviations see Table 1. done separately in patients with RA with and without positive bone marrow iron stores, because some parameters can be influenced by both disease activity and iron deficiency, and in control subjects. No significant correlation could be detected between any of the indicators of disease activity and iron absorption values.
Discussion
Iron metabolism is disturbed in states of inflammation. Even one single period of fever may produce a rapid and prolonged decrease of serum iron and an increase of serum ferritin concentration. gested that iron stores in affected joints are responsible for the relatively high concentration of serum ferritin in patients with RA, even in subjects with depleted bone marrow iron stores. 27 In this study we found that absorption of iron was decreased in patients with RA, both with normal and depleted iron stores. In patients with RA with normal bone marrow iron stores mucosal uptake of iron did not differ from that in normal controls. Those with depleted iron stores, however, were unable to increase mucosal iron uptake to the same extent as patients with uncomplicated iron deficiency. As a result the absolute amount of iron transported by the mucosal cells of iron depleted patients with RA was much lower than in patients with uncomplicated iron deficiency, despite lack of difference in the mucosal transfer fraction.
Our patients with RA represented a wide range of disease activity. The complete lack of correlation between the indicators of RA activity and the absorption of iron, although iron absorption is significantly decreased in active RA, means that factors causing the decrease of iron absorption must be fully operative early during activation of RA. It was striking that depletion of bone marrow iron stores, being highly correlated with both mucosal uptake and mucosal transfer of iron in control subjects, had no influence on mucosal uptake in active RA. Further investigation should be directed to the production of iron carriers in the microvillus membrane and cytosol of mucosal cells, which apparently do not react on development of iron deficiency elsewhere in the body. The transfer of iron from the mucosal cell to the plasma is correlated with the availability of free transferrin iron binding sites, probably best represented by the unbound iron binding capacity. The difference in mucosal transfer between controls and patients with active RA may be the result of an absolute decrease of circulating transferrin or of a decreased turnover of free binding sites. For better assessment of these factors a combination of iron absorption with ferrokinetic studies is needed. Also, submucosal tissue macrophages may act as a trap during passage of iron to the plasma.
In our two groups of patients with RA, with and without iron deficiency, the mean haemoglobin concentrations were virtually identical. We suppose, however, that the decreased iron retention will, in the long run, contribute to the development or persistence of iron deficiency anaemia in patients with RA. If the same mechanisms operate for therapeutic iron administration the correction of iron deficiency in patients with RA by oral iron treatment may be more difficult and time consuming than in patients with uncomplicated iron deficiency. 
